FHTX · CIK 0001822462 · FY2025 live · 2025-12-31
Foghorn Therapeutics Inc.
View as
Model
Classic Z
FY2025
−5.34
Zone
Distress
Prior
—
Market DD
—
1y PD
—
Meridian Rank
15.45
0–100 · Classic Z tape · not a PD
Book standing
16
Year change
—
Market PD
—
O-score
14
−5.34
Z″ −10.28
Score −5.34 · distress below 1.80, grey to 2.99, safe at 3.00 and above.
Classic Z factor contributions
X1 Working capital / assets
Short-term liquidity versus the size of the balance sheet.
0.521.2 × = 0.63X2 Retained earnings / assets
Cushion from years of profits. Share buybacks can push this negative at otherwise healthy firms.
−3.191.4 × = −4.47X3 EBIT / assets
Operating return on assets. Highest weight in the original model.
−0.443.3 × = −1.44X4 Book equity / liabilities
Book equity versus the liability stack. Mega-caps often look greyer here than they would if X4 used market cap.
−0.350.6 × = −0.21X5 Sales / assets
Asset turnover — how much revenue the asset base supports.
0.161 × = 0.16
Five-year path
Need two annual 10-Ks to draw a path. The desk will pull this issuer’s filings rather than invent a series.
Overview
rule-v1
Foghorn Therapeutics Inc. is on classic Z at −5.34 (distress) for FY2025, from an SEC 10-K. Retained earnings / assets is the line that sets the print. This is the first live year on the desk. No market tape loaded. Classic Z was fit on manufacturers; buybacks can send retained earnings negative at otherwise healthy issuers, and X4 is book equity, not market cap.
Book screen Distress; market PD —. Tape not priced — not a single default call.
Market DD · naive Merton
No market tape yet.
Pull a year of closes (Yahoo, Nasdaq if Yahoo is limited) and size equity from Nasdaq cap or EDGAR shares. Distance-to-default and 1-year PD stay blank until then.
Sector peers
Closest Classic Z scores · 28th percentile in Healthcare.
- HURADistressTuHURA Biosciences, Inc./NV−5.33
- PBYIDistressPUMA BIOTECHNOLOGY, INC.−5.32
- SLDBDistressSolid Biosciences Inc.−5.37
- CRBUDistressCaribou Biosciences, Inc.−5.29
- CMMBDistressChemomab Therapeutics Ltd.−5.27
- CERSDistressCERUS CORP−5.25
- ALECDistressAlector, Inc.−5.45
- LEEEFDistressLeef Brands Inc.−5.21
KPI widgets
Current assets
$163M
Total assets
$198M
Current liabilities
$60M
Total liabilities
$307M
Working capital
$103M
Retained earnings
−$632M
EBIT
−$86M
Total sales
$31M
Book equity
−$109M
Accession 0001628280-26-016814. Live rank is the latest 10-K on EDGAR (FY2025, period 2025-12-31). Classic Z is the live score. View as does not rewrite the live rank. X4 is book equity. Pulled 13 Sept 2026.